Portfolio

We have tailored our approach to help companies navigate specific challenges in biomanufacturing.

Exceptional technology and scientific proof point

Our in-house scientific expertise and advisors rigorously vet potential investments to validate the science and its potential. Clear ownership of patents and sound patent strategy.

Inflection point and strong early traction

At their key inflection: vetted scientific proof-point and ready for early commercial scale. Product development and/or licensing agreements in place.

Commercial viability and large addressable market

Innovations must have a clear path to commercialization and cost parity. Product revenue of at least $100M per annum.

Outstanding Founders

Strong founding team combines scientific and operational expertise with high growth potential and drive to grow their business.

Federal funding access potential

Track record of high-level grants from government bodies and biomanufacturing funding programs.

Outsized exit potential

Minimum 20x potential and valuation of >$1 billion upon exit if successful.